Literature DB >> 19956074

Soft drink consumption and obesity: it is all about fructose.

George A Bray1.   

Abstract

PURPOSE OF REVIEW: The purpose of the review is to suggest that fructose, a component of both sucrose (common sugar) and high fructose corn syrup, should be of concern to both healthcare providers and the public. RECENT
FINDINGS: Consumption of sugar-sweetened beverages has increased steadily over the past century and with this increase has come more and more reports associating their use with the risk of overweight, diabetes and cardiometabolic disease. In a meta-analysis of the relationship between soft drink consumption and cardiometabolic risk, there was a 24% overall increased risk comparing the top and bottom quantiles of consumption. Several factors might account for this increased risk, including increased carbohydrate load and increased amounts of dietary fructose. Fructose acutely increases thermogenesis, triglycerides and lipogenesis as well as blood pressure, but has a smaller effect on leptin and insulin release than comparable amounts of glucose. In controlled feeding studies, changes in body weight, fat storage and triglycerides are observed as well as an increase in inflammatory markers.
SUMMARY: The present review concludes on the basis of the data assembled here that in the amounts currently consumed, fructose is hazardous to the cardiometabolic health of many children, adolescents and adults.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19956074     DOI: 10.1097/MOL.0b013e3283346ca2

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  41 in total

Review 1.  Laboratory animals as surrogate models of human obesity.

Authors:  Cecilia Nilsson; Kirsten Raun; Fei-fei Yan; Marianne O Larsen; Mads Tang-Christensen
Journal:  Acta Pharmacol Sin       Date:  2012-02       Impact factor: 6.150

2.  Increased hepatic de novo lipogenesis and mitochondrial efficiency in a model of obesity induced by diets rich in fructose.

Authors:  Raffaella Crescenzo; Francesca Bianco; Italia Falcone; Paola Coppola; Giovanna Liverini; Susanna Iossa
Journal:  Eur J Nutr       Date:  2012-04-28       Impact factor: 5.614

3.  Digging deeper into obesity.

Authors:  Rexford S Ahima
Journal:  J Clin Invest       Date:  2011-06-01       Impact factor: 14.808

Review 4.  A possible link between hepatic mitochondrial dysfunction and diet-induced insulin resistance.

Authors:  Raffaella Crescenzo; Francesca Bianco; Arianna Mazzoli; Antonia Giacco; Giovanna Liverini; Susanna Iossa
Journal:  Eur J Nutr       Date:  2016-02       Impact factor: 5.614

5.  High-fructose corn syrup causes characteristics of obesity in rats: increased body weight, body fat and triglyceride levels.

Authors:  Miriam E Bocarsly; Elyse S Powell; Nicole M Avena; Bartley G Hoebel
Journal:  Pharmacol Biochem Behav       Date:  2010-02-26       Impact factor: 3.533

6.  Effects of high-fructose corn syrup and sucrose on the pharmacokinetics of fructose and acute metabolic and hemodynamic responses in healthy subjects.

Authors:  Myphuong T Le; Reginald F Frye; Christopher J Rivard; Jing Cheng; Kim K McFann; Mark S Segal; Richard J Johnson; Julie A Johnson
Journal:  Metabolism       Date:  2011-12-05       Impact factor: 8.694

7.  Will reducing sugar-sweetened beverage consumption reduce obesity? Evidence supporting conjecture is strong, but evidence when testing effect is weak.

Authors:  K A Kaiser; J M Shikany; K D Keating; D B Allison
Journal:  Obes Rev       Date:  2013-06-07       Impact factor: 9.213

8.  Maitake mushroom extracts ameliorate progressive hypertension and other chronic metabolic perturbations in aging female rats.

Authors:  Harry G Preuss; Bobby Echard; Debasis Bagchi; Nicholas V Perricone
Journal:  Int J Med Sci       Date:  2010-06-07       Impact factor: 3.738

Review 9.  Possible links between intestinal permeability and food processing: A potential therapeutic niche for glutamine.

Authors:  Jean Robert Rapin; Nicolas Wiernsperger
Journal:  Clinics (Sao Paulo)       Date:  2010-06       Impact factor: 2.365

Review 10.  Fructose and cardiometabolic disorders: the controversy will, and must, continue.

Authors:  Nicolas Wiernsperger; Alain Geloen; Jean-Robert Rapin
Journal:  Clinics (Sao Paulo)       Date:  2010-07       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.